Fred W. Alvarez, Colleen Heisey Join Jones Day

Tuesday, April 16, 2013 - 14:47

Fred W. Alvarez is joining Jones Day as a partner in the Silicon Valley office, where he will be a member of Jones Day's Labor & Employment Practice. Mr. Alvarez is joining from the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he was a partner and the leader of the firm's Employment Law Litigation Practice. 

"Fred is one of the preeminent leaders in Labor & Employment in the United States, with significant experience defending employers in individual, multi-plaintiff and class action lawsuits brought by private and governmental parties," said Lawrence DiNardo, who heads the global Labor & Employment Practice at Jones Day. "He will be an excellent addition to our L&E team in California and throughout the United States."

Prior to his career in private practice, Mr. Alvarez held two different President-appointed government positions: assistant secretary of labor for the U.S. Department of Labor (responsible for the Wage and Hour Division and the Office of Federal Contract Compliance Programs) from 1987 to 1989 and commissioner of the U.S. Equal Employment Opportunity Commission (EEOC) from 1984 to 1987. Mr. Alvarez earned his undergraduate degree from Stanford University and his law degree from Stanford Law School and recently was named to the board of trustees of Stanford University. He is also a former president of the Bar Association of San Francisco.

Mr. Alvarez works in all areas of employment law, including devoting substantial attention to strategic, preventive and compliance advice and internal investigations. In addition, he focuses a portion of his time on serving as a court-appointed monitor of class action decrees and settlement agreements.

* * *

Colleen Heisey has joined the Washington office of Jones Day as a partner in the Health Care Practice. Formerly a partner in Hunton & Williams, LLP's Washington office, Ms. Heisey focuses on food and drug law with a particular emphasis on advertising, promotion and compliance counseling.
 
"We're delighted that Colleen has chosen to join us and bring her vast experience in a highly dynamic regulatory arena to bear for our clients," said Greg Shumaker, partner-in-charge of Jones Day's Washington office. "The many changes happening in the healthcare industry will have ripple effects in a variety of regulatory areas and her experience adds even more to our depth in providing a full complement of services to a variety of healthcare and life sciences clients."
 
Ms. Heisey advises on regulatory and compliance issues for drug, biologic, food, dietary supplement, medical device and cosmetic products, including product promotion and advertising, good manufacturing practice requirements, product recalls, FDA inspection, and warning letters. She has provided regulatory oversight and compliance assessment for due diligence audits of drug, medical device, and food companies, including those related to product safety, product labeling, product marketing and advertising, and consumer complaints. Her legal support services for pharmaceutical advertising and promotional activities for drug, medical device, and food companies include ongoing review of product marketing materials and programs; real-time monitoring and feedback of on-the-ground activities related to sales and marketing; regulatory and legal comments and direction in development of direct-to-consumer broadcast advertising; and audits of pharmaceutical and medical device company sales, marketing and medical affairs activities, as well as drug sampling programs.
 
"Healthcare and life sciences companies are under increasing scrutiny from the FDA, USDA, and other federal and state regulatory agencies," said James Dutro, the San Francisco-based co-leader of Jones Day's Health Care Practice. "Colleen's deep understanding of the regulations and the regulators adds significantly to the formidable capabilities we have assembled to counsel clients worldwide on the evolving regulatory environment." 

* * *

On April 15, Greg Castanias, an Issues & Appeals partner in the Washington office and head of the firm's Federal Circuit practice, began arguing before the U.S. Supreme Court on behalf of respondents in Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398. This closely watched case presents the question of whether isolated molecules of DNA are eligible for patent under 35 U.S.C. §101, as well as an antecedent question of Article III jurisdiction. The outcome of the case is of great significance to the biotechnology industry, and has attracted upwards of 40 amicus briefs. Respondents' brief can be found at www.jonesdayappellate.com/iasupremecourt/SupremeCourt.aspx.

 

Mr. Castanias's experience includes several arguments and appearances before the U.S. Supreme Court, as well as over 40 arguments and approximately 150 appearances before the Federal Circuit. He also has argued several cases before other federal courts of appeals and in state supreme courts from Alaska to Connecticut.